$1.10
+0.02 (+1.85%)
Open$1.07
Previous Close$1.08
Day High$1.10
Day Low$1.04
52W High$12.23
52W Low$1.02
Volume—
Avg Volume223.2K
Market Cap15.55M
P/E Ratio—
EPS$-6.21
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+3,874.5% upside
Current
$1.10
$1.10
Target
$43.72
$43.72
$35.70
$43.72 avg
$58.20
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 26.99M | 4.18M | 3.97M |
| Net Income | -91,104,568 | -1,151,363 | -1,086,006 |
| Profit Margin | -16,993.3% | -27.6% | -27.4% |
| EBITDA | -91,267,239 | -1,394,086 | -1,159,340 |
| Free Cash Flow | — | -921,744 | -1,324,564 |
| Rev Growth | — | +11.5% | +10.2% |
| Debt/Equity | — | 0.72 | 0.66 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |